I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Can
http://www.clinicaltrials.gov/ct2/sh...y+stage&rank=8
Drug: Neratinib Drug: ABT-888 Drug: Standard Therapy Drug: AMG 386 Drug: AMG 479 (Ganitumab) plus Metformin Drug: MK-2206 with or without Trastuzumab Drug: AMG 386 and Trastuzumab Drug: T-DM1 and Pertuzumab Drug: Pertuzumab and Trastuzumab I-Spy is in Phase II and could be a great opportunity for someone to receive less toxic treatment and improve standard of care. |
All times are GMT -7. The time now is 09:16 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021